Management Iii Llc Venrock, 10% Owner at Vitae Pharmaceuticals, Inc (VTAE), bought 777,700 shares at $8.00 ($6.2M) on 2014-09-29, disclosed to the SEC on 2014-10-01.
Open-market purchase of $6.2M VTAE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,367 | $0 | 0.0% |
| 2 | $8.00 | 15,446 | $124K | 2.0% |
| 3 | $8.00 | 139,019 | $1.1M | 18.0% |
| 4 | $8.00 | 617,868 | $4.9M | 80.0% |
| Total | $7.94 avg | 777,700 | $6.2M | 100% |